Zonisamide USP for Compounding (API) is an active pharmaceutical ingredient used to formulate medications for managing seizures in epilepsy. As an anticonvulsant, it stabilizes electrical activity in the brain, helping to control partial and generalized seizures. In compounding, pharmacists can tailor dosages and formulations to individual patient needs, enhancing therapeutic effectiveness and minimizing side effects. Customization is especially beneficial for those requiring specific dosing adjustments or alternative administration forms due to unique health conditions or treatment responses.

Ships in 2-4 business days.

Zonisamide USP is a prescription medication that is primarily used to treat seizures and epilepsy. It is also sometimes prescribed off-label for other neurological conditions such as migraines, neuropathic pain, and bipolar disorder. When used for compounding, Zonisamide USP can be specially formulated into various dosage forms, such as capsules, oral suspensions, or topical creams, depending on the patient's specific needs and preferences. These compounded medications can provide a more customized and effective treatment option for patients who may not respond well to commercially available forms of Zonisamide or who have difficulty swallowing pills.

CAS Number: 68291-97-4